Skip to content

Public FDA record

Z-2054-2020: Cranio/Sculpt C, 10cc, Bone Void Filler, UDI: 00813845021129 - Product Usage: CRANIO/SCULPT C is a calciu

Recall record Z-2054-2020 for Skeletal Kinetics, Llc. View source facts, labeled dates, and the original FDA record.

FDA identifier
Z-2054-2020
Company in FDA record
Skeletal Kinetics, Llc
FDA record creation date
May 20, 2020
First observed by MedTech Watch
Nov 16, 2026
Latest observed content change
Nov 16, 2026
Recall classification
Class II

Reason stated in the source

Potential product mix-up. The recalling firm has determined that one unit of OsteoVation EX, 3cc that may not have been sterilized was inadvertently packaged as CranioSculpt C, 10cc.

Source facts

Action
The recalling firm notified their customer regarding the medical device recall via email; the recall notice was issued on 04/03/2020. The recalling firm is requesting that affected customers: (1) review the letter in full, review current inventory, and complete and return the Acknowledgement and Receipt Form via email; and (2) return unused inventory via Federal Express (contact the recalling firm for a FedEx shipping account number to cover shipping costs) with reference to Return Material Authorization RMA# 8. If there has been further distribution of the affected devices to other subaccounts, communicate the recall information immediately and conduct a sub-recall to those accounts; request that they immediately cease distribution of the affected devices and return the product. Subsequently, contact the recalling firm for instructions on returning the recalled product received from the subaccounts. Report any adverse health consequences or quality problems experienced with the use of the product to the recalling firm. Events may also be reported to FDA's MedWatch Adverse Event Reporting program online: www.fda.gov/medwatch/report.htm. The following are actions to be taken by Clinical Providers: For a patient that may have been implanted with a product where sterility cannot be assured, it is recommended clinical judgement be used in monitoring and/or treating any potential signs of infection. The firm has initiated the voluntary recall and is requesting that any remaining product from the affected lot be returned. The lot of product was originally returned on November 30, 2018 after a reported complaint was received. The firm confirmed the correct contents of the 76 returned kits and then re-issued the kits on November 30, 2018. The firm has conducted further investigation and is now initiating this recall for the re-issued products. Direct contact information for questions concerning this voluntary recall is the following: Monday-Friday, 8
Initiated
2020-04-03
Root cause
Process design
Terminated
2025-01-30
Distribution
US Nationwide distribution in the state of Florida.
Recall number
Z-2054-2020
Recall status
Terminated
CDRH record ID
181131
FDA record created
2020-05-20
Recall event number
85516

Source facts and excerpts are reproduced for research. Dates retain their source meanings. “First observed” describes collection, not FDA publication or product launch.

Recall classification is supplied only when the recall number matches an enforcement record. Recall class and device class are different fields. Several recall records may belong to one recall event.

Useful context

Device classifications

FDA dataset:

Last successful check: Nov 22, 2026

Source classifications may change.

510(k) clearances

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset monthly.

Recall records

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset weekly.

Keep this research moving.

Follow ten competitors and ten product codes. Get matching changes in your dashboard and a weekly brief, for $49/month.

Start a 14-day free trial ↗